Chao Yu

1.3k total citations · 1 hit paper
52 papers, 873 citations indexed

About

Chao Yu is a scholar working on Molecular Biology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Chao Yu has authored 52 papers receiving a total of 873 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Epidemiology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Chao Yu's work include Liver Disease Diagnosis and Treatment (6 papers), COVID-19 Clinical Research Studies (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Chao Yu is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), COVID-19 Clinical Research Studies (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Chao Yu collaborates with scholars based in China, Hong Kong and United States. Chao Yu's co-authors include Wenhua Ling, Jieshou Li, Hongliang Xue, Weiming Zhu, Yi Li, Yuqing Deng, Yuan Zhang, Xu Chen, Chen Shen and Yan Yang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Circulation Research.

In The Last Decade

Chao Yu

49 papers receiving 862 citations

Hit Papers

Gut Microbially Produced Indole-3-Propionic Acid Inhibits... 2022 2026 2023 2024 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chao Yu China 16 334 146 126 120 102 52 873
Tarun Tyagi India 13 351 1.1× 123 0.8× 75 0.6× 131 1.1× 87 0.9× 23 1.1k
Shan Zhou China 18 435 1.3× 91 0.6× 79 0.6× 105 0.9× 103 1.0× 58 1.0k
Yequn Chen China 15 231 0.7× 102 0.7× 69 0.5× 89 0.7× 78 0.8× 55 779
Pietro E. Cippà Switzerland 19 491 1.5× 82 0.6× 140 1.1× 169 1.4× 217 2.1× 55 1.3k
Laura Márquez‐Expósito Spain 15 400 1.2× 77 0.5× 77 0.6× 91 0.8× 119 1.2× 31 916
Jin Liu China 20 355 1.1× 90 0.6× 78 0.6× 116 1.0× 160 1.6× 121 1.3k
Chengping Hu China 18 381 1.1× 192 1.3× 111 0.9× 152 1.3× 162 1.6× 50 1.2k
Alireza Khabbazi Iran 22 336 1.0× 109 0.7× 57 0.5× 81 0.7× 76 0.7× 135 1.4k
Hui Ding China 21 552 1.7× 140 1.0× 283 2.2× 170 1.4× 135 1.3× 67 1.5k

Countries citing papers authored by Chao Yu

Since Specialization
Citations

This map shows the geographic impact of Chao Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chao Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chao Yu more than expected).

Fields of papers citing papers by Chao Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chao Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chao Yu. The network helps show where Chao Yu may publish in the future.

Co-authorship network of co-authors of Chao Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Chao Yu. A scholar is included among the top collaborators of Chao Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chao Yu. Chao Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Chao, et al.. (2025). A Modified Intrabony Defect Model of Periodontitis in Rat. Oral Diseases. 31(7). 2261–2272. 1 indexed citations
3.
Xue, Hongliang, Liqing Wang, Dianjianyi Sun, et al.. (2025). Associations of Alcohol Consumption and Genetic Predisposition to Hepatic Steatosis With Liver-Related Events: Results From Large Population-Based Cohort Studies. Gastroenterology. 169(4). 705–714.e14. 2 indexed citations
4.
Yu, Chao, et al.. (2024). Prognostic value of immunotherapy in advanced NSCLC based on baseline and dynamic changes in HALP. SHILAP Revista de lepidopterología. 25(1). 29–41. 2 indexed citations
5.
Chen, Xiaohong, Tao Xu, Chao Yu, et al.. (2024). A Dual‐domain Engineered Antibody for Efficient HBV Suppression and Immune Responses Restoration. Advanced Science. 11(15). e2305316–e2305316. 2 indexed citations
6.
Zhang, Chi, Lan Tan, Juan Li, et al.. (2024). REV-ERBα Inhibits Osteoclastogenesis and Protects against Alveolar Bone Loss. Journal of Dental Research. 104(2). 193–203. 2 indexed citations
7.
Yu, Chao, Jingli Wang, Junjie Shao, et al.. (2024). Direct endovascular treatment may be more appropriate for patients with good collateral circulation: a retrospective case-control study. Quantitative Imaging in Medicine and Surgery. 14(12). 8915–8926.
8.
Yu, Chao, Yiwen Ruan, Xiaobo Sun, et al.. (2023). rTMS ameliorates depression/anxiety-like behaviors in experimental autoimmune encephalitis by inhibiting neurotoxic reactive astrocytes. Journal of Affective Disorders. 331. 352–361. 7 indexed citations
9.
Mi, Baibing, Yutong Wang, Kang Zhu, et al.. (2023). The effects of comorbidities on the change of taste and smell in COVID‐19 patients. Laryngoscope Investigative Otolaryngology. 8(1). 25–33. 1 indexed citations
10.
Xia, Cui, et al.. (2023). Serum exosome-derived miR-146a-3p promotes macrophage M2 polarization in allergic rhinitis by targeting VAV3 via PI3K/AKT/mTOR pathway. International Immunopharmacology. 124(Pt B). 110997–110997. 10 indexed citations
11.
Xue, Hongliang, Xu Chen, Chao Yu, et al.. (2022). Gut Microbially Produced Indole-3-Propionic Acid Inhibits Atherosclerosis by Promoting Reverse Cholesterol Transport and Its Deficiency Is Causally Related to Atherosclerotic Cardiovascular Disease. Circulation Research. 131(5). 404–420. 150 indexed citations breakdown →
12.
Liu, Jianrong, Chao Yu, Qing Yang, et al.. (2021). The clinical implication of gamma-glutamyl transpeptidase in COVID-19. Liver Research. 5(4). 209–216. 15 indexed citations
13.
Zhu, Kang, Cui Xia, Jingguo Chen, et al.. (2021). Serum Soluble ST2 Correlated with Symptom Severity and Clinical Response of Sublingual Immunotherapy for House Dust Mite‐Induced Allergic Rhinitis Patients. Mediators of Inflammation. 2021(1). 5576596–5576596. 8 indexed citations
14.
Zhao, Yan, et al.. (2020). Peripheral blood inflammatory markers in predicting prognosis in patients with COVID‐19. Some differences with influenza A. Journal of Clinical Laboratory Analysis. 35(1). e23657–e23657. 32 indexed citations
15.
Zhang, Zhigang, et al.. (2020). Study on the combination of brief psychodynamic psychotherapy with Viagra in the treatment of non-organic ED. General Psychiatry. 33(5). e100184–e100184. 2 indexed citations
16.
Shen, Tianran, Xu Chen, Yan‐Ping Li, et al.. (2017). Interleukin-17A exacerbates high-fat diet-induced hepatic steatosis by inhibiting fatty acid β-oxidation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1863(6). 1510–1518. 27 indexed citations
18.
Tian, Yun, Weiming Zhu, Jianfeng Gong, et al.. (2013). Triptolide induces suppressor of cytokine signaling-3 expression and promotes lamina propria mononuclear cells apoptosis in Crohn's colitis. International Immunopharmacology. 16(2). 268–274. 22 indexed citations
19.
Yu, Chao, Ting Shan, Aiwen Feng, et al.. (2011). Triptolide ameliorates Crohn's colitis is associated with inhibition of TLRs/NF-κB signaling pathway. Fitoterapia. 82(4). 709–715. 34 indexed citations
20.
Feng, Aiwen, Chao Yu, Qing Mao, et al.. (2011). Berberine hydrochloride attenuates cyclooxygenase-2 expression in rat small intestinal mucosa during acute endotoxemia. Fitoterapia. 82(7). 976–982. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026